Position in BNTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,238,898
+$9,007,943 QoQ
Shares Held
103,948
+4184.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GROUP ONE TRADING LLC holds $126,528,527 across 209 Biotechnology names. BNTX ranks #2 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
363,997 | $23,991,042 | |
| 2 | BNTX |
BioNTech SE
This page
|
103,948 | $9,238,898 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
211,817 | $6,892,525 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
173,279 | $5,862,028 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
96,001 | $4,566,767 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,357 | $4,178,274 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,399 | $4,171,483 | |
| 8 | ABVX |
Abivax S.A.
|
35,767 | $3,982,655 |
All Filings in BNTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,238,898 | 103,948 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $230,955 | 2,426 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,624,298 | 57,030 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,833,743 | 73,577 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,764,462 | 63,304 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,528,904 | 66,072 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $1,835,827 | 15,457 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,282,464 | 53,291 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,337,502 | 47,019 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,484,386 | 51,965 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,993,731 | 73,580 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,217,393 | 29,810 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,621,000 | 29,068 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,453,165 | 49,615 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $6,742,111 | 49,986 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $14,280,052 | 95,775 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $35,308,990 | 207,018 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $38,060,045 | 147,634 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $25,563,329 | 93,642 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $14,550,185 | 64,991 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $7,570,688 | 69,335 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,423,420 | 17,461 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $340,057 | 4,912 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $583,107 | 8,737 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||